← All stories
Markets
UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy
The company is now hoping for an affirmative answer on its application after an unusually turbulent year dealing with U.S. regulators.
Covered by 1 outlet
All coverage · 1 article